Literature DB >> 22936789

The essential role of Giα2 in prostate cancer cell migration.

Miao Zhong1, Shineka Clarke, BaoHan T Vo, Shafiq A Khan.   

Abstract

Cell- and receptor-specific regulation of cell migration by Gi/oα-proteins remains unknown in prostate cancer cells. In the present study, oxytocin (OXT) receptor was detected at the protein level in total cell lysates from C81 (an androgen-independent subline of LNCaP), DU145 and PC3 prostate cancer cells, but not in immortalized normal prostate luminal epithelial cells (RWPE1), and OXT-induced migration of PC3 cells. This effect of OXT has been shown to be mediated by Gi/oα-dependent signaling. Accordingly, OXT inhibited forskolin-induced luciferase activity in PC3 cells that were transfected with a luciferase reporter for cyclic AMP activity. Although mRNAs for all three Giα isoforms were present in PC3 cells, Giα2 was the most abundant isoform that was detected at the protein level. Pertussis toxin (PTx) inhibited the OXT-induced migration of PC3 cells. Ectopic expression of the PTx-resistant Giα2-C352G, but not wild-type Giα2, abolished this effect of PTx on OXT-induced cell migration. The Giα2-targeting siRNA was shown to specifically reduce Giα2 mRNA and protein in prostate cancer cells. The Giα2-targeting siRNA eliminated OXT-induced migration of PC3 cells. These data suggest that Giα2 plays an important role in the effects of OXT on PC3 cell migration. The Giα2-targeting siRNA also inhibited EGF-induced migration of PC3 and DU145 cells. Expression of the siRNA-resistant Giα2, but not wild type Giα2, restored the effects of EGF in PC3 cells transfected with the Giα2-targeting siRNA. In conclusion, Giα2 plays an essential role in OXT and EGF signaling to induce prostate cancer cell migration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936789      PMCID: PMC3475741          DOI: 10.1158/1541-7786.MCR-12-0219

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  37 in total

1.  Mitotic activity and cell deletion in ventral prostate epithelium of intact and castrated oxytocin-treated rats.

Authors:  B Plećas; A Popović; D Jovović; M Hristić
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.

Authors:  Marta Busnelli; Aude Saulière; Maurice Manning; Michel Bouvier; Celine Galés; Bice Chini
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

Review 3.  Pertussis toxin and target eukaryotic cells: binding, entry, and activation.

Authors:  H R Kaslow; D L Burns
Journal:  FASEB J       Date:  1992-06       Impact factor: 5.191

4.  Physical and immunological characterization of a guanine nucleotide-binding protein purified from bovine cerebral cortex.

Authors:  R M Huff; J M Axton; E J Neer
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

5.  Essential role for G proteins in prostate cancer cell growth and signaling.

Authors:  P F Kue; Y Daaka
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

6.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

Review 7.  G proteins in cancer: the prostate cancer paradigm.

Authors:  Yehia Daaka
Journal:  Sci STKE       Date:  2004-01-13

8.  Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas.

Authors:  Paola Cassoni; Tiziana Marrocco; Anna Sapino; Elena Allia; Gianni Bussolati
Journal:  Int J Oncol       Date:  2004-10       Impact factor: 5.650

9.  Contractile activity of vasotocin, oxytocin, and vasopressin on mammalian prostate.

Authors:  M Bodanszky; H Sharaf; J B Roy; S I Said
Journal:  Eur J Pharmacol       Date:  1992-06-05       Impact factor: 4.432

10.  Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function.

Authors:  Miao Zhong; Amy M Navratil; Colin Clay; Barbara M Sanborn
Journal:  Biochemistry       Date:  2004-03-30       Impact factor: 3.162

View more
  8 in total

1.  Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.

Authors:  Xiao-Shan Min; Peng Huang; Xu Liu; Chao Dong; Xiao-Lin Jiang; Zheng-Tai Yuan; Lin-Feng Mao; Shi Chang
Journal:  Tumour Biol       Date:  2015-04-24

2.  Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.

Authors:  Smrruthi Vaidegi Venugopal; Silvia Caggia; DaJhnae Gambrell-Sanders; Shafiq A Khan
Journal:  Prostate       Date:  2020-01-29       Impact factor: 4.104

3.  Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.

Authors:  Silvia Caggia; HimaBindu Chunduri; Ana C Millena; Jonathan N Perkins; Smrruthi V Venugopal; BaoHan T Vo; Chunliang Li; Yaping Tu; Shafiq A Khan
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

4.  The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer.

Authors:  Huan Xu; Shi Fu; Qi Chen; Meng Gu; Juan Zhou; Chong Liu; Yanbo Chen; Zhong Wang
Journal:  Oncotarget       Date:  2017-05-09

5.  MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.

Authors:  Xiaodan Fu; Yimin Li; Ayesha Alvero; Juanni Li; Qihui Wu; Qing Xiao; Yulong Peng; Yongbin Hu; Xiang Li; Wenguang Yan; Ke Guo; Wenjuan Zhou; Yong Wang; Junwen Liu; Yu Zhang; Gil Mor; Jifang Wen; Gang Yin
Journal:  Oncotarget       Date:  2016-12-06

6.  Follicle-Stimulating Hormone Induces Lipid Droplets via Gαi/o and β-Arrestin in an Endometrial Cancer Cell Line.

Authors:  Niamh S Sayers; Priyanka Anujan; Henry N Yu; Stephen S Palmer; Jaya Nautiyal; Stephen Franks; Aylin C Hanyaloglu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

7.  Suppression of GNAI2 message in ovarian cancer.

Authors:  John R Raymond; Kathryn M Appleton; Jennifer Y Pierce; Yuri K Peterson
Journal:  J Ovarian Res       Date:  2014-01-14       Impact factor: 4.234

8.  Small Molecule Inhibitors Targeting Gαi2 Protein Attenuate Migration of Cancer Cells.

Authors:  Silvia Caggia; Subhasish Tapadar; Bocheng Wu; Smrruthi V Venugopal; Autumn S Garrett; Aditi Kumar; Janae S Stiffend; John S Davis; Adegboyega K Oyelere; Shafiq A Khan
Journal:  Cancers (Basel)       Date:  2020-06-19       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.